OctoPlus N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 05 jan 2012 - 07:31

Statutaire naam OctoPlus N.V.

Titel OctoPlus announces expansion of drug delivery contract with top-5 pharmaceutical company

Bericht OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO) announces today that it has won an expansion of its drug delivery technology evaluation contract with an existing client, a top-5 global pharmaceutical company. OctoPlus has performed feasibility work for previous compounds of this client in 2009 and 2010 and those studies have been successful. Pre-clinical studies performed with the prototype controlled release formulation were also successful.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

201201040000000017_OctoPlus announces expansion of drug delivery evaluation contract with top-5 pharmaceutical company.pdf (opens in a new window)

201201040000000017_OctoPlus verkrijgt uitbreiding van evaluatiecontract voor zijn technologie van top-5 farmaceut.pdf (opens in a new window)

Datum laatste update: 09 november 2024